Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDP-108 in Patients With Onychomycosis
NCT00777868Phase 2Completed
- Sponsor
- Dow Pharmaceutical Sciences
- Start
- Oct 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of efinaconazole in onychomycosis, sponsored by Dow Pharmaceutical Sciences. Started Oct 2007; status: completed.
02
Drugs
efinaconazole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT00777868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00777868.